TerrAscend (OTCMKTS:TSNDF) Shares Down 1% – Should You Sell?

Posted by ABMN Staff on Feb 5th, 2026

TerrAscend Corp. (OTCMKTS:TSNDF – Get Free Report)’s stock price dropped 1% during mid-day trading on Wednesday . The stock traded as low as $0.6150 and last traded at $0.6830. Approximately 401,961 shares were traded during mid-day trading, an increase of 82% from the average daily volume of 220,576 shares. The stock had previously closed at $0.6899.

Wall Street Analyst Weigh In

TSNDF has been the subject of several analyst reports. Zacks Research downgraded shares of TerrAscend from a “hold” rating to a “strong sell” rating in a research note on Monday, January 12th. Canaccord Genuity Group raised shares of TerrAscend to a “strong-buy” rating in a research report on Thursday, October 9th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy”.

Check Out Our Latest Stock Analysis on TerrAscend

TerrAscend Stock Performance

The company has a debt-to-equity ratio of 2.54, a current ratio of 1.56 and a quick ratio of 1.12. The stock has a market capitalization of $210.23 million, a P/E ratio of -1.67 and a beta of 1.41. The company has a fifty day moving average of $0.72 and a two-hundred day moving average of $0.73.

TerrAscend (OTCMKTS:TSNDF – Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). TerrAscend had a negative return on equity of 18.32% and a negative net margin of 42.72%.The firm had revenue of $65.10 million during the quarter, compared to analyst estimates of $65.97 million. On average, equities analysts anticipate that TerrAscend Corp. will post -0.14 EPS for the current year.

TerrAscend Company Profile

(Get Free Report)

TerrAscend is a vertically integrated cannabis company that operates across cultivation, processing and retailing in North America. The company’s business model spans seed-to-sale activities, enabling it to manage quality control, production efficiency and product innovation from its growing facilities through to its distribution networks. TerrAscend serves both adult-use and medical cannabis markets, offering a full suite of cannabis derivatives including dried flower, concentrates, vapes, edibles, tinctures and topicals.

Geographically, TerrAscend maintains operations in key regulated markets.